Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Aldeyra Therapeutics, Inc. (ALDX)

« Back to company index

ALDX Chatter Timeline

Stock Ticker for ALDX

Most Active Tweeters for ALDX

UserTweets
@AmericanBanking 5
@SelfThink4 4
@WeekHerald 4
@BlueBioNow 3
@dakotafinancial 3

Recent Tweets for ALDX

dakotafinancial @dakotafinancial
Aldeyra Therapeutics $ALDX Stock Rating Reaffirmed by Cantor Fitzgerald https://t.co/DpjabFIhFf
October 21st 2019, 3:10am
RatingsNetwork @RatingsNetwork
Cantor Fitzgerald Sets Aldeyra Therapeutics FY2019 Earnings Estimates at ($2.19) EPS. https://t.co/VuUkyjLKub $ALDX #ALDX
October 21st 2019, 2:10am
AmericanBanking @AmericanBanking
Aldeyra Therapeutics, Inc $ALDX Receives Average Rating of “Buy” from Analysts https://t.co/HU15HAJMVy #stocks
October 21st 2019, 1:10am
OlympiaReport @OlympiaReport
Aldeyra Therapeutics, Inc $ALDX Receives Average Rating of “Buy” from Analysts https://t.co/oEQmPBnROt
October 21st 2019, 1:10am
WeekHerald @WeekHerald
Aldeyra Therapeutics, Inc $ALDX Receives Consensus Recommendation of “Buy” from Analysts https://t.co/RXJWSF6Skg
October 21st 2019, 1:10am
gcassidy718 @gcassidy718
$ALDX a bit volatility -4.71 % change recently https://t.co/h8Yudy9fHu
October 20th 2019, 8:10pm
TickerReport @TickerReport
Cantor Fitzgerald Reiterates “Overweight” Rating for Aldeyra Therapeutics $ALDX https://t.co/DjvQk8gNQ4
October 20th 2019, 1:10am
WeekHerald @WeekHerald
Aldeyra Therapeutics’ $ALDX “Overweight” Rating Reiterated at Cantor Fitzgerald https://t.co/yF0PGXmvEB
October 20th 2019, 1:10am
BlueBioNow @BlueBioNow
$ALDX buyer at $6.23 -4.71 % change recently https://t.co/PJmOd2fRWo
October 19th 2019, 11:10pm
ThisLincolnian @ThisLincolnian
Aldeyra Therapeutics $ALDX Rating Reiterated by Cantor Fitzgerald https://t.co/sNM1MgwZqr
October 19th 2019, 2:10pm
ZolmaxNews @ZolmaxNews
Aldeyra Therapeutics $ALDX Rating Reiterated by Cantor Fitzgerald https://t.co/mISCeURFsf
October 19th 2019, 2:10pm
bbnsnews @bbnsnews
Aldeyra Therapeutics $ALDX Rating Reiterated by Cantor Fitzgerald https://t.co/yM1kX4avJj
October 19th 2019, 2:10pm
AmericanBanking @AmericanBanking
Aldeyra Therapeutics $ALDX Earns “Overweight” Rating from Cantor Fitzgerald https://t.co/iXYCtdgPji #stocks
October 19th 2019, 8:10am
dispatchtribune @dispatchtribune
Aldeyra Therapeutics $ALDX Earns “Overweight” Rating from Cantor Fitzgerald https://t.co/TO0mOYHFph
October 19th 2019, 8:10am
registrarjourn @registrarjourn
Aldeyra Therapeutics $ALDX Earns “Overweight” Rating from Cantor Fitzgerald https://t.co/8i6MDu1Y8v
October 19th 2019, 7:10am
EnterpriseLeade @EnterpriseLeade
Aldeyra Therapeutics $ALDX Earns “Overweight” Rating from Cantor Fitzgerald https://t.co/YUMYXVayEz
October 19th 2019, 7:10am
bbnsnews @bbnsnews
Aldeyra Therapeutics, Inc $ALDX Short Interest Update https://t.co/E56VtYV3K7
October 19th 2019, 1:10am
gcassidy718 @gcassidy718
$ALDX considerable price movement -2.53 % change recently https://t.co/h8Yudy9fHu
October 18th 2019, 5:10pm
SelfThink4 @SelfThink4
$ALDX GL to all holding. Data soon. Cheers!
October 18th 2019, 11:10am
dakotafinancial @dakotafinancial
Aldeyra Therapeutics $ALDX Upgraded to Hold at Zacks Investment Research https://t.co/nptpyWuE6m
October 18th 2019, 3:10am
macondailynews @macondailynews
Aldeyra Therapeutics $ALDX Upgraded to Hold at Zacks Investment Research https://t.co/FzcBcFOUcR
October 18th 2019, 3:10am
dailypoliticaln @dailypoliticaln
Aldeyra Therapeutics, Inc $ALDX Sees Large Decline in Short Interest https://t.co/X65Uqnawl1
October 18th 2019, 1:10am
ZolmaxNews @ZolmaxNews
Aldeyra Therapeutics, Inc $ALDX Sees Large Decline in Short Interest https://t.co/hfJZKWgOKt
October 18th 2019, 1:10am
ZolmaxNews @ZolmaxNews
Aldeyra Therapeutics $ALDX Shares Up 9.9% https://t.co/PcF8BCtaVB
October 18th 2019, 12:10am
BlueBioNow @BlueBioNow
$ALDX significant price movement on this stock 2.35 % change recently https://t.co/PJmOd2fRWo
October 17th 2019, 7:10pm
AmericanBanking @AmericanBanking
Aldeyra Therapeutics, Inc $ALDX Short Interest Update https://t.co/b4V6qo98E8 #stocks
October 17th 2019, 3:10am
TranscriptDaily @TranscriptDaily
Aldeyra Therapeutics, Inc $ALDX Short Interest Update https://t.co/zg4I24EIU6
October 17th 2019, 3:10am
OlympiaReport @OlympiaReport
Aldeyra Therapeutics, Inc $ALDX Short Interest Update https://t.co/9eOh17PrVJ
October 17th 2019, 3:10am
dispatchtribune @dispatchtribune
Zacks: Analysts Expect Aldeyra Therapeutics, Inc $ALDX to Announce -$0.53 Earnings Per Share https://t.co/Jcjq8J983V
October 16th 2019, 7:10pm
ConsumerFeed @ConsumerFeed
Aldeyra Therapeutics, Inc $ALDX Expected to Announce Earnings of -$0.53 Per Share https://t.co/Z19kl9IfCJ
October 16th 2019, 7:10pm
SelfThink4 @SelfThink4
$ALDX firm trading today. https://t.co/TdXvUVMcs5
October 16th 2019, 3:10pm
brendan_49 @brendan_49
@PhilKobi The counter argument as Klendathu notes is that the best DES drug is probably at $ALDX which is being assigned negligible value.
October 16th 2019, 8:10am
KlendathuCap @KlendathuCap
@brendan_49 Look at $aldx to see what value the market attributes to companies that go after eye indications...
October 16th 2019, 7:10am
TheMarketsDaily @TheMarketsDaily
Analyzing Deciphera Pharmaceuticals $DCPH and Aldeyra Therapeutics $ALDX https://t.co/IB9wEfIx4e
October 16th 2019, 3:10am
ConsumerFeed @ConsumerFeed
Aldeyra Therapeutics $ALDX Stock Rating Upgraded by Zacks Investment Research https://t.co/JZIAJTEQ42
October 16th 2019, 3:10am
SelfThink4 @SelfThink4
$ALDX unusual activity, keep eyes on for next week. $MRKR ? https://t.co/uNtKGD9NIy
October 15th 2019, 11:10pm
fm23 @fm23
$ALDX https://t.co/0t3oPu5WeY
October 15th 2019, 7:10pm
HeadlinesFin @HeadlinesFin
Is Aldeyra Therapeutics, Inc. $ALDX's Fuel For Real? The Stock Just Increased Again https://t.co/fBJQj3CSad
October 15th 2019, 2:10pm
TheMarketsDaily @TheMarketsDaily
Aldeyra Therapeutics $ALDX Upgraded to Hold at Zacks Investment Research https://t.co/ukF3gbYh2H
October 15th 2019, 10:10am
stocknewstimes @stocknewstimes
Aldeyra Therapeutics $ALDX Upgraded to “Hold” by Zacks Investment Research https://t.co/i3rQ1RRlXp
October 15th 2019, 10:10am
WeekHerald @WeekHerald
Aldeyra Therapeutics $ALDX Upgraded at Zacks Investment Research https://t.co/y1Bji53ZM6
October 14th 2019, 5:10pm
ThisLincolnian @ThisLincolnian
Aldeyra Therapeutics $ALDX Upgraded at Zacks Investment Research https://t.co/sovfsoyJfr
October 14th 2019, 5:10pm
littlecreepy @littlecreepy
@biotechinvstr $ALDX long with $HALO close second
October 14th 2019, 1:10pm
ThisLincolnian @ThisLincolnian
-$0.53 Earnings Per Share Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/bG3AnK7qSO
October 14th 2019, 11:10am
IlliniJJ @IlliniJJ
back in $RGNX and $ALDX with 1/2 positions on this mornings down moves.
October 14th 2019, 9:10am
TickerSentiment @TickerSentiment
Sentiment for $ALDX out of 3 total scores; 100 % is positive and 0 % is negative. #sentiment https://t.co/RMsEhs4a6Y
October 14th 2019, 8:10am
ProVesting @ProVesting
$ALDX $TOT: 4 Stocks To Watch For October 14, 2019: https://t.co/s05ToFtMQi
October 14th 2019, 4:10am
PennyStocksMomo @PennyStocksMomo
RT @BenzingaMedia: $TOT, $ALDX 4 Stocks To Watch For October 14, 2019 - https://t.co/s91yRLIcwi
October 14th 2019, 4:10am
BenzingaMedia @BenzingaMedia
$TOT, $ALDX 4 Stocks To Watch For October 14, 2019 - https://t.co/s91yRLIcwi
October 14th 2019, 3:10am
WeekHerald @WeekHerald
Analysts Expect Aldeyra Therapeutics, Inc $ALDX Will Announce Earnings of -$0.53 Per Share https://t.co/KjSNKAxbcs
October 12th 2019, 6:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.